Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy

The present invention relates to methods and pharmaceutical compositions for the prophylactic treatment of peritoneal carcinomatosis. In particular, the present invention relates to a method for the prophylactic treatment of peritoneal carcinomatosis in a patient in need thereof comprising administering to the patient a therapeutically effective combination of at least one dextrin polysaccharide and at least one chemotherapeutic agent.

Keywords: Peritoneal carcinomatosis, dextrin polysaccharide
Patent Application number: European Procedure (Patents) (EPA) - 04 Févr. 2016 - 16 305 126.1
Inventors:
null
Publications:
Eur J Surg Oncol. 2017 Jun;43(6):1088-1094. doi: 10.1016/j.ejso.2016.12.009. Epub 2017 Jan 9.

Reference:

BIO15407-T1

    Business Developper
    contact
    Anne COCHI
    Business Development Manager
    Patent filling date: 04-02-2016
    Rare disease: No
    Second indication: No

    You might also be interested in